NCT00384085 - "Insulin Glargine All to Target Trial" | Biotech Hunter

Enrollment

588

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin Glulisine

Subcutaneous injection up to 1 injection per day

DRUG

Insulin Glargine

Subcutaneous injection once-a-day

DRUG

Premixed Insulin

Subcutaneous injection twice-a-day.

DRUG

Insulin Glulisine

Subcutaneous injection up to 3 injections per day.

Trial Locations (1)

Sanofi-Aventis Administrative Office, Bridgewater